[The study of alveolar macrophage nitroblue tetrazolium reduction in patients with lung cancer].
Authors studied experimentally PAM NBT reduction function in patients with lung cancer. Results indicate that PMN and lymphocyte counts in the lung cancer group are significantly lower than that in the control group, and NBT reduction of PAM is significantly decreased. We conclude that host defense and immune function in patients with lung cancer are decreased.
Zhang
X L
XL
Department of Respiratory Medicine China-Japan Friendship Hospital.
D000328:Adult; D000368:Aged; D001992:Bronchoalveolar Lavage Fluid / Q000473:pathology; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D008175:Lung Neoplasms / Q000378:metabolism / Q000473:pathology*; D016676:Macrophages, Alveolar / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000473:pathology; D009580:Nitroblue Tetrazolium / Q000378:metabolism*; D010084:Oxidation-Reduction; D012907:Smoking
D009580:Nitroblue Tetrazolium